Seller record · bluumpeptides.com

Bluum Peptides

Fails 4 of 8 criteria. S1, prescriber requirement: No clinician appears anywhere on the site, and every product page restricts use to in vitro testing and laboratory experimentation. 3 more criteria also fail; see the table below.

At a glance

Bluum Peptidesbluumpeptides.com

4/8criteria passed
Price
Retatrutide from $125 for a 10 mg vial
Sells
retatrutide, cagrilintide, mazdutide, and 15 more
FDA letters
None on file
Visit Bluum PeptidesSee all eight dispositions

Research vendor. Passes 4 of 8 criteria. Recorded against Standard v1.1.

A research peptide store selling retatrutide, cagrilintide, mazdutide and about fifty other compounds with an open cart, and a lot lookup that links purity, endotoxin and sterility reports. Its own pages print three different business addresses in Wyoming and Texas.

Operating entity Bluum LLC

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementFAILbluumpeptides.com/products/retatrutide
S2Prescription gatingFAILbluumpeptides.com/products/retatrutide
S3Pharmacy identificationFAILbluumpeptides.com
S4Compounding disclosurePASSbluumpeptides.com
S5Analytical documentationPASSbluumpeptides.com/pages/coa-lookup?lot=BLP-5859103-P
S6Business addressFAILbluumpeptides.com/policies/terms-of-service
S7Price disclosurePASSbluumpeptides.com/products/retatrutide
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1FAILNo clinician appears anywhere on the site, and every product page restricts use to in vitro testing and laboratory experimentation.Source: bluumpeptides.com/products/retatrutide.
S2FAILProducts add to cart directly from the product page, and the only gate is a yes or no prompt confirming age twenty one.Source: bluumpeptides.com/products/retatrutide.
S3FAILThe footer states that Bluum is a chemical supplier and neither a 503A compounding pharmacy nor a 503B outsourcing facility.Source: bluumpeptides.com.
S4PASSThe seller offers no compounded drug, and every page footer states that the products serve research only and are not for human consumption.Source: bluumpeptides.com.
S5PASSThe retatrutide page links a public Horizon Analytical certificate reporting 99.34 percent purity on lot BLP-5859103-P, and the lot archive adds Freedom Diagnostics reports, while the homepage credits Janoshik Analytical and BioRegen, named on none of these documents.Source: bluumpeptides.com/pages/coa-lookup?lot=BLP-5859103-P.
S6FAILThe seller prints three different addresses: a Sheridan, Wyoming suite in the footer, a Lakeway, Texas mailing address in the terms, and an Austin, Texas return address in the refund policy.Source: bluumpeptides.com/policies/terms-of-service.
S7PASSThe retatrutide page prints $125 for one 10 mg vial and the BPC-157 page prints $39 for one 5 mg vial, with no account required to see either price.Source: bluumpeptides.com/products/retatrutide.
S8PASSNo FDA warning letter names Bluum Peptides or Bluum LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: retatrutide, cagrilintide, mazdutide, eloralintide, BPC-157, TB-500, GHK-Cu, NAD+, MOTS-c, PT-141, tesamorelin, ipamorelin, sermorelin, semax, epitalon, glutathione, KPV, peptide blends.

Unpaid link. Bluum Peptides does not pay the site, and nothing is earned when it is used. Funding.

Visit Bluum Peptides

127 sellers pass S1, prescriber requirement

Records dated August 2026

Records dated September 2026

See all 127 on the S1 criterion page — 119 more than shown here.

This seller fails criteria a medical service must meet. The records above belong to sellers that pass S1; some are partner links, disclosed on their records.

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.